Your abstract submission must adhere the following structure:

• The maximum number of characters is 3,200 (excl. spaces) including the title and the author block. The title should be short (maximum 170 characters).
• Please enter your name and the names of co-authors as given in the example below. Start each name with a capital letter and continue in lower case, do not enter names/affiliations all in capital letters.
  First Name: John
  2nd Initial:  J
  3rd Initial:   R
  Last Name: Macleod
• The abstract must be structured. Enter each section into the corresponding text field with the provided sub-headings in bold (Background and aims, Materials and methods, Results and Conclusion). The abstract structuring words are fixed for each abstract text box. One or two sentences should describe the methods, and any aspects of methodology (e.g. use of control groups, randomisation, patient selection, assay variation). The sentences stating the results must include hard data, including statistical analysis. The abstract requires solid data, i.e. n, p-values and confidence intervals if appropriate.
• It is allowed to include only one table OR one graph to your abstract, but 400 characters will be deducted from the maximum number of characters allowed. Tables must be uploaded as an image; so you must create your table and convert it into an image in order to include it in your abstract. You can edit your table or graph and then replace it, or delete it until the submission deadline of 1 April 2025, 18:00hrs CEST. Do not enter both (a table and a graph) in the same image file; also, do not create and upload multi panel images (a maximum of two panels is allowed). When creating a table, do not exceed a number of 10 columns and 12 rows with a maximum of 1 line per row! 
• References are not allowed.
• For drugs exclusively generic names should be used (no trademarks).
• A list of approved abbreviations and units of expression for use without definition appears in Diabetologia.
• Grant/Support information must be entered in its designated field, not in the abstract body.
• Where applicable, the Clinical Trial Registration Number must be entered into its designated field, not in the abstract body.
• Only one keyword can be selected.
• Abstracts CANNOT be submitted as an e-mail attachment.

Once all submission steps have been successfully completed and the abstract deadline has passed, a notification confirming the final version of the abstract submission will be posted on the presenting author’s Scientific Submission portal (accessible by loging into MyEASD). All notifications will be posted ONLY on the presenting = first named author’s Scientific Submission portal, the name, middle name, last name and e-mail contact used during the submission process must match any existing EASD membership and/or MyEASD account (only one e-mail address per presenting = first named author).

In case of questions, or if no notification confirming the final version of the abstract submission has been received by 14 April 2025, please contact the EASD office: abstracts@easd.org 

Keywords

One keyword from the list available here must be selected for the submission:

Scientific Programme Committee

Preference for oral presentation or short oral discussion is not possible, they rank equally. The Scientific Programme Committee allocates the accepted abstracts to either an oral presentation or a short oral discussion session. The Scientific Programme Committee Members will meet in May 2025 and have the absolute right to accept or reject abstracts. Their decision is final. Only accepted abstracts will be published in the Abstract Volume.

The Scientific Programme Committee’s decision will be posted ONLY on the presenting = first named author’s Scientific Submission portal, the name, middle name, last name and e-mail contact used during the submission process must match any existing EASD membership and/or MyEASD account (only one e-mail address per presenting = first named author).

Oral and Short Oral Presentations during the EASD Annual Meeting will be delivered live; will also be made available on the EASD Media Centre.

EASD is a non-profit organisation and as such not subject to VAT which also applies to the registration fees.